Clinical Trial Results: Ambispective Study to Assess the Safety and the Performance of SAGITTA EVL R Stem

View source ↗

Summary

Phase 1/2 ambispective trial results assessing safety and performance of SAGITTA EVL R Stem for hip arthropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Arthropathy

Drugs mentioned

• SAGITTA EVL R Stem

Snippet

Sponsor: Societe dEtude, de Recherche et de Fabrication | Conditions: Hip Arthropathy | Status: COMPLETED | Results posted: 2026-06-30